Skip to main content

Table 5 COX regression analysis for long-term mortality

From: Characteristics and outcomes of Stanford type A aortic dissection patients with severe post-operation hyperbilirubinemia: a retrospective cohort study

Characteristic

Univariate COX regression

Multivariate COX regression

OR (95%CI)

P value

OR (95%CI)

P value

Age

1.023 (1.003–1.043)

0.026

  

Preoperative

 SCr

1.006 (1.002–1.010)

< 0.001

  

 APACHE II score

1.122 (1.060–1.188)

< 0.001

  

 MELD score

1.052 (1.003–1.105)

0.039

  

Intraoperative

 Operation duration

1.248 (1.098–1.414)

0.001

  

 CPB time

1.005 (1.002–1.008)

0.001

  

Postoperative

 MAP

0.971 (0.957–0.985)

< 0.001

0.979 (0.962–0.995)

0.012

 The total amount of blood transfusion

1.009 (1.007–1.011)

< 0.001

  

 Mechanical ventilation time

1.035 (1.020–1.051)

< 0.001

  

 AKI (yes/no)

6.25 (2.295–17.024)

< 0.001

  

 Stage of AKI

 

< 0.001

 

< 0.001

  Stage 1

1.404 (0.506–3.901)

0.515

1.037 (0.365–2.946)

0.946

  Stage 2

2.772 (0.929–8.271)

0.068

2.236 (0.774–6.990)

0.133

  Stage 3

15.071 (6.043–37.587)

< 0.001

12.604 (5.002–31.762)

< 0.001

 Use of CRRT (yes/no)

6.368 (4.174–9.709)

< 0.001

  

 Use of PE/BA (yes/no)

3.184 (1.596–6.351)

0.001

  

 Use of ECMO (yes/no)

6.108 (2.638–14.139)

< 0.001

12.167 (4.588–32.264)

< 0.001

 Onset of hyperbilirubinemia

1.217 (1.044–1.418)

0.012

  

 Peak TB concentration

1.004 (1.003–1.006)

< 0.001

  

 Peak TB > 121 μmol/l (yes/no)

2.595 (1.679–4.001)

< 0.001

  

 Peak TB > 171 μmol/l (yes/no)

2.292 (1.488–3.530)

< 0.001

  

 Time to peak TB concentration

1.156 (1.107–1.208)

< 0.001

  

ICU stay time

1.037 (1.022–1.053)

< 0.001

  
  1. ACC Aortic cross clamp, AKI Acute kidney injury, APACHEII Acute physiology and chronic health evaluation II, BA Bilirubin adsorption, CPB Cardiopulmonary bypass, CRRT Continuous renal replacement therapy, ECMO Extracorporeal membrane oxygenation, ICU Intensive care unit, MAP Mean arterial pressure, MELD Model for end-stage liver disease, PE Plasma exchange, SCr Serum creatinine, TB Total bilirubin